Sappanone A Ameliorates Cisplatin-induced Cytotoxicity Via Nrf2/HO-1 Signaling in HK-2 Cells

Guona Zheng1, Yang Liu1, Bingjie Li1

  • 1Department of Pathology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.

Abstract

Insights

Sappanone A protects kidney cells from cisplatin damage by activating the Nrf2 pathway, reducing oxidative stress, apoptosis, and inflammation. Nrf2 gene silencing reversed these protective effects, confirming Nrf2

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Toxicology

Background:

  • Cisplatin (CP) is a widely used chemotherapy agent with significant nephrotoxicity.
  • The Nrf2 signaling pathway plays a crucial role in cellular defense against oxidative stress and inflammation.
  • Sappanone A (SA), derived from Caesalpinia sappan L., exhibits potential therapeutic properties.

Purpose of the Study:

  • To elucidate the role of the Nrf2 signaling pathway in SA-mediated protection against CP-induced renal injury.
  • To investigate the impact of Nrf2 knockdown on apoptosis, oxidative stress, NF-κB activation, and IL-1β release in HK-2 cells.

Main Methods:

  • siRNA-mediated Nrf2 gene knockdown in human renal proximal tubular HK-2 cells.
  • Quantification of oxidative stress markers (MDA, •OH) and IL-1β levels.
  • Assessment of apoptosis via TUNEL staining and flow cytometry.
  • Western blot analysis for Nrf2, HO-1, p65, and p-p65 protein expression.

Main Results:

  • Nrf2 knockdown significantly abrogated SA's protective effects against CP-induced oxidative stress and apoptosis.
  • SA treatment reduced CP-induced p-p65 levels, an effect abolished by Nrf2 depletion.
  • Nrf2 silencing increased IL-1β secretion, indicating heightened inflammation.

Conclusions:

  • SA mitigates CP-induced nephrotoxicity by activating the Nrf2 pathway, thereby suppressing oxidative stress, apoptosis, and inflammation.
  • The Nrf2 pathway is essential for the antioxidant, anti-inflammatory, and anti-apoptotic effects of SA in renal cells.
  • Targeting the Nrf2 pathway may offer a therapeutic strategy to reduce cisplatin-induced kidney damage.